Maria Concepcion Castells, Ph.D., M.D.
This page shows the publications co-authored by Maria Castells and Aleena Banerji.
Drug desensitization in the coronavirus disease 2019 pandemic era: Local success to widespread potential. Ann Allergy Asthma Immunol. 2021 06; 126(6):739-741.
Reply to "Penilloate and penicilloate concentrations in practical guidance recommendations". J Allergy Clin Immunol Pract. 2021 03; 9(3):1419-1420.
Practical Guidance for the Evaluation and Management of Drug Hypersensitivity: Specific Drugs. J Allergy Clin Immunol Pract. 2020 10; 8(9S):S16-S116.
Practical Guidance for the Evaluation and Management of Drug Hypersensitivity: General Concepts. J Allergy Clin Immunol Pract. 2020 10; 8(9S):S3-S15.
Controversies in Allergy: Chemotherapy Reactions, Desensitize, or Delabel? J Allergy Clin Immunol Pract. 2020 10; 8(9):2907-2915.e1.
Cephalosporin Allergy: Current Understanding and Future Challenges. J Allergy Clin Immunol Pract. 2019 Sep - Oct; 7(7):2105-2114.
Report from the National Institute of Allergy and Infectious Diseases workshop on drug allergy. J Allergy Clin Immunol. 2015 Aug; 136(2):262-71.e2.
The connection strength for co-authors is the sum of the scores for each of their shared publications.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.